Abstract

SummaryBackgroundPortal hypertension (PH) causes severe complications in patients with liver cirrhosis, such as variceal bleeding and ascites; however, data on the knowledge and perceptions on guideline recommendations for the management of varices and the use of albumin is scarce.MethodsWe designed two structured surveys on (i) the management of varices and (ii) the use of albumin for Austrian physicians of specialized Gastro-Intestinal (GI) centers. The interviewed physicians were confronted spontaneously and provided ad hoc responses to the questionnaire.ResultsIn total, 158 surveys were completed. Interestingly, many specialists (30%) would recommend a follow-up gastroscopy after 1 year in patients with compensated cirrhosis without varices (i.e., overtreatment). For small varices, 81.5% would use non-selective beta blockers (NSBB) for primary prophylaxis (PP). For PP in patients with large varices, endoscopic band ligation (EBL) plus NSBB was preferred by 51.4% (i.e., overtreatment). Knowledge on the indication criteria for early TIPS (transjugular intrahepatic portosystemic shunt) was reported by 54.3%, but only 20% could report these criteria correctly. The majority (87.1%) correctly indicated a preference to use NSBB and EBL for secondary prophylaxis (SP).The majority of participating gastroenterologists reported no restrictions on the use of albumin (89.8%) in their hospitals. Of the interviewed specialists, 63.6% would use albumin in patients with SBP; however, only 11.4% would use the doses recommended by guidelines. The majority of specialists indicated using albumin at the recommended doses for hepatorenal syndrome (HRS-AKI, 86.4%) and for large volume paracentesis (LVP, 73.3%). The individual responses regarding albumin use for infections/sepsis, hyponatremia, renal impairment, and encephalopathy were heterogeneous.ConclusionThe reported management of PH and varices is mostly adherent to guidelines, but endoscopic surveillance in patients without varices is too intense and EBL is overused in the setting of PP. Knowledge on the correct use of early TIPS must be improved among Austrian specialists. Albumin use is widely unrestricted in Austria; however, albumin is often underdosed in established indications.Electronic supplementary materialThe online version of this article (10.1007/s00508-020-01769-9) contains supplementary material, which is available to authorized users.

Highlights

  • Portal hypertension (PH) causes severe complications in patients with cirrhosis, including ascites, acute variceal bleeding (AVB), hepatorenal syndrome (HRSAKI), and spontaneous bacterial peritonitis (SBP) [1,2,3]

  • The reported management of PH and varices is mostly adherent to guidelines, but endoscopic surveillance in patients without varices is too intense and endoscopic band ligation (EBL) is overused in the setting of PP

  • Knowledge on the correct use of early transjugular intrahepatic portosystemic shunt (TIPS) must be improved among Austrian specialists

Read more

Summary

Introduction

Portal hypertension (PH) causes severe complications in patients with cirrhosis, including ascites, acute variceal bleeding (AVB), hepatorenal syndrome (HRSAKI), and spontaneous bacterial peritonitis (SBP) [1,2,3]. The European Association for the Study of the Liver (EASL) issued clinical practice guidelines on the management of ascites and its complications and more recently, decompensated liver cirrhosis [3, 6]. For primary prophylaxis of variceal bleeding, current international guidelines recommend either nonselective beta blockers (NSBB) or endoscopic band ligation (EBL); Austrian guidelines indicate a preference for NSBB [2, 13]. More than half of the patients in this bicentric study received EBL plus NSBB in primary prophylaxis, the current guidelines do not recommend this regimen in this setting [2, 13, 14]. There is an ongoing controversy regarding the use of NSBB in patients with refractory ascites with or without spontaneous bacterial peritonitis (SBP) [18,19,20,21], which likely impacts on the use of NSBB for bleeding prophylaxis by treating physicians, especially in patients with a history of ascites

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call